McKesson Corporation and Clayton, Dubilier & Rice have secured $3.1 billion in financing from Wall Street banks for their acquisition of Option Care Health. Following this, five firms increased their price targets for McKesson, with the average 12-month target now at $1,122.71, suggesting a 5% upside from its November 4 close, while analysts maintained a consensus "Buy" rating.
Original sourceMCKESSON CORP
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1,060.84
-1.04%
Alpha Vantage · 11/6/2026
One-year price history
Adjusted daily closes · 252 observations · as of Nov 6, 2026
1 month
+14.0%
3 months
+20.7%
6 months
+44.4%
1 year
+24.0%
Year to date
+29.7%
52-week range
$723.61 – $1,072.00
Fundamental snapshot
Latest reported period: Sep 30, 2026
Market cap
$122.48B
P/E
26.1
P/B
-31
P/S
0.3
Revenue
$418.79B
Net income
$4.7B
Diluted EPS
38.83
Gross margin
3.70%
Net margin
1.10%
Return on equity
-161.20%
Total debt
$11.16B
Cash
$6.53B
Free cash flow
$6.87B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $110.96B | $1.22B | 3.60% | 1.10% | $2.95B |
| Jun 30, 2026 | $105.38B | $614M | 3.50% | 0.60% | -$372M |
| Mar 31, 2026 | $96.3B | $1.68B | 4.20% | 1.70% | $3.24B |
| Dec 31, 2025 | $106.16B | $1.19B | 3.50% | 1.10% | $1.06B |
| Sep 30, 2025 | $103.15B | $1.11B | 3.40% | 1.10% | $2.22B |
| Jun 30, 2025 | $97.83B | $784M | 3.40% | 0.80% | -$1.11B |
| Mar 31, 2025 | $90.82B | $1.26B | 4.00% | 1.40% | $7.47B |
| Dec 31, 2024 | $95.29B | $879M | 3.40% | 0.90% | -$2.58B |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MCK news
All market newsOption Care Health reported a 4.1% increase in net revenue for Q3 2026, reaching $1.493 billion, and an adjusted EBITDA increase of 4.3% to $124.6 million. The company has withdrawn its financial guidance and did not host an earnings call due to its pending acquisition by Clayton, Dubilier & Rice, LLC and McKesson Corporation.
Original source